News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 253–288
- Matches
- 1610
- Sources here
- 21
- Companies here
- 29
Active search
1610 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Telomir Pharmaceuticals | 10-Q: Q2 2026 Earnings Report
This article provides the Q2 2026 earnings report for Telomir Pharmaceuticals, detailing their financial performance for the quarter. It is a direct summary of the company's 10-Q filing.
DeFi Development Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
DeFi Development Corp. has reported its earnings results for the second quarter and six months ended June 30, 2026. For the second quarter, the company saw sales increase to $3.31 million from $1.99 million a year ago, but experienced a net loss of $27.29 …
ETFs Investing in Exelon Corporation Stocks
This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Exelon Corporation (1EXC) stocks. It details various ETFs, their market value of Exelon holdings, weight percentage, issuer, management style, expense ratio, assets under management (AUM), current price, change, relative volume, and …
Exelon (EXC) Restores Power As Fair Value Still Sits Above The Stock
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Exelon (EXC) is back in focus after its Commonwealth Edison unit restored power to more than 80% of customers affected by severe storms …
Sharemaestro market context Price below Trend Line 52 weeks -2.6%5 Must-Read Analyst Questions From Regal Rexnord’s Q2 Earnings Call
5 Must-Read Analyst Questions From Regal Rexnord's Q2 Earnings Call Regal Rexnord's second quarter saw its sales growth fall short of Wall Street's expectations, driving a significant negative market reaction. Management attributed the shortfall to persistent weakness in residential HVAC and pool markets, as …
Melcor Developments Q2 Profit Rises
(RTTNews) - Melcor Developments (MRD.TO) released earnings for its second quarter that Increased, from the same period last year The company's bottom line came in at C$21.94 million, or C$0.73 per share. This compares with C$7.26 million, or C$0.24 per share, last year. The …
RRX|Regal Rexnord Corp|Price:172.306|Chg%:-0.594
This article provides a detailed financial overview of Regal Rexnord Corp (RRX), including its stock price, key figures, and recent performance. It highlights the company's stock score, analyst ratings, and technical analysis, showing a "Buy" consensus with a target price significantly above the current …
Telos (NASDAQ:TLS) Director Derrick Dockery Sells 11,000 Shares of Stock
Telos Director Derrick Dockery recently sold 11,000 shares of the company's stock for $47,740, reducing his direct ownership by 6.13%. This transaction follows Telos's positive quarterly earnings report, where the company beat EPS and revenue estimates, causing its shares to rise by 6.0%. Despite …
DeFi Development Corp. (DFDV) swings to $110.7M loss on Solana strategy
DeFi Development Corp. (DFDV) reported a significant net loss of $110.7 million for the first half of 2026, primarily due to severe losses on its digital asset holdings and derivatives tied to Solana (SOL) financing. Despite a substantial increase in revenue from its Digital …
Jefferies Just Upgraded Five Below Stock. Here's Why.
Jefferies has upgraded Five Below (FIVE) stock, raising its price target to $350 due to anticipated structural improvements and strong comparable sales growth. Analyst Randal Konik projects significant upside for the discount retailer, driven by consistent productivity gains and store network expansion. While the …
Artelo Biosciences Releases Q2 2026 Financial Results
Artelo Biosciences, Inc. reported a net loss of $2.4M and a loss of $0.89 per share for Q2 2026, marking a significant improvement from the $16.8 per-share loss in Q2 2025. The clinical-stage biopharmaceutical company continues to advance its therapeutic pipeline targeting lipid-signaling pathways, …
Artelo Plans Q4 Trial After ART26.12 Matches Naproxen for Pain
Artelo Biosciences reported its Q2 2026 financial results, with a narrowed net loss of $2.4 million and positive pipeline updates. The company plans a Phase 1 multiple ascending dose study for ART26.12 in Q4 2026, which has shown pain relief comparable to naproxen in …
Artelo Biosciences (ARTL) investors disclose 4.8% stake via Intracoastal warrant
Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC have disclosed a 4.8% beneficial ownership stake in Artelo Biosciences (ARTL) through a warrant held by Intracoastal. This ownership amounts to 173,914 shares of common stock, issuable upon the warrant's exercise, and is based …
Five Below Shares Rise After Jefferies Upgrade
Five Below (FIVE) shares rose after Jefferies upgraded the stock from Hold to Buy, increasing its price target from $210 to $350. This positive analyst action highlights renewed confidence in the specialty retailer's prospects. The article also mentions recent company news, including the opening …
Five Below Has No Business Selling a Bow Mirror This Chic for $25
Five Below is selling a new coquette-style floor-length bow mirror for just $25, offering a high-end look at a fraction of the price of similar designer versions, such as one from Pottery Barn Teen. The mirror features a sleek design with a white ribbon-style …
Jefferies upgrades Five Below to buy, sees path to TJX-like re-rating
Investing.com -- Jefferies upgraded Five Below to Buy from Hold and raised its price target to $350 from $210, arguing that investors are underestimating structural improvements at the discount retailer and focusing too heavily on the temporary boost from its popular "squishy" products. The …